Redundancy or cell-type-specific regulation?: Tumour necrosis factor in alveolar macrophages and mast cells

被引:22
作者
Déry, RE
Lin, TJ
Befus, AD
Milne, CD
Moqbel, R
Ménard, G
Bissonnette, EY
机构
[1] Hop Laval, Ctr Rech Pneumol, Ste Foy, PQ G1V 4G5, Canada
[2] Univ Alberta, Dept Med, Pulm Res Grp, Edmonton, AB, Canada
[3] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada
[4] Univ Laval, Hosp Laval, Heart & Lung Inst, Dept Med, Ste Foy, PQ, Canada
关键词
D O I
10.1046/j.1365-2567.2000.00982.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumour necrosis factor (TNF) is an important inflammatory cytokine produced by several cell types. To test the hypothesis that there is cell-type-specific regulation and not redundancy of TNF production, we investigated its production by alveolar macrophages (AM) and peritoneal mast cells (PMC). Cell lysates of freshly isolated AM and PMC contained 9 +/- 3 pg and 57 +/- 17 pg of TNF/10(6) cells, respectively. Furthermore, unstimulated PMC expressed 4 x 10(3)-fold more attomols of TNF mRNA/mu g total RNA compared with AM. These data may explain in part the greater TNF-dependent cytotoxicity of PMC. Furthermore, fixed PMC showed significantly higher TNF-dependent cytotoxic activity than AM (sevenfold), suggesting that PMC express more membrane TNF than AM. Although AM and PMC contain different amounts of TNF, antigen stimulation caused a similar release of TNF from sensitized rats. Interferon (IFN)-gamma, respectively, stimulated and inhibited AM and PMC TNF-dependent cytotoxicity whereas lipopolysaccharide (LPS) significantly stimulated TNF-dependent cytotoxicity in both cell types. However, TNF released (AM 400-fold and PMC threefold) and TNF mRNA expression, as measured by competitive reverse transcription-polymerase chain reaction (AM 7 x 10(3)-fold and PMC twofold), were considerably greater in LPS-stimulated AM than PMC. Our data indicate that TNF is differentially expressed in these two cell types and that its production is dependent on the nature of the stimulus. These data provide vital basis in experimental approaches aimed at modulating the effect of TNF in airway disease conditions involving both AM and mast cells.
引用
收藏
页码:427 / 434
页数:8
相关论文
共 30 条
[1]  
BEFUS AD, 1994, MUCOSAL IMMUNOLOGY C, P307
[2]  
BEUTLER B, 1992, TUMOR NECROSIS FACTO, P561
[3]  
BISSONNETTE EY, 1991, J IMMUNOL, V147, P3060
[4]   Histamine inhibits tumor necrosis factor alpha release by mast cells through H-2 and H-3 receptors [J].
Bissonnette, EY .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1996, 14 (06) :620-626
[5]  
BISSONNETTE EY, 1995, IMMUNOLOGY, V86, P12
[6]  
BISSONNETTE EY, 1990, J IMMUNOL, V145, P3385
[7]  
Daftary SS, 1998, LUNG BIOL HEALTH DIS, V117, P361
[8]   JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS [J].
DARNELL, JE ;
KERR, IM ;
STARK, GR .
SCIENCE, 1994, 264 (5164) :1415-1421
[9]  
DECKER T, 1987, J IMMUNOL, V138, P957
[10]   IFN-γ potentiates the release of TNF-α and MIP-1α by alveolar macrophages during allergic reactions [J].
Déry, RE ;
Bissonnette, EY .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (03) :407-412